PETS PetMed Express Inc.

PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors

PetMed Express, Inc. Announces Appointment of Leah Solivan to Board of Directors

Visionary founder and investor brings decades of experience building and scaling digital consumer brands

DELRAY BEACH, Fla., June 24, 2024 (GLOBE NEWSWIRE) -- , dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) (the "Company") today announced the appointment of Leah Solivan to the Company’s Board of Directors (“the Board”), effective June 24, 2024. Solivan brings over 20 years of experience building and scaling technology businesses to the Company’s Board. As a General Partner at Fuel Capital, she focuses on early-stage investments across a variety of sectors, including consumer technology, hardware, education, marketplaces, and retail. Her entrepreneurial acumen is exemplified by her founding of TaskRabbit in 2008, which she steered through significant growth phases before orchestrating its successful acquisition by IKEA in 2017.

“Leah’s strong digital background and proven track record of scaling technology-driven businesses from startups to billion-dollar enterprises will make her an invaluable advisor and member of our Board. Leah has demonstrated a remarkable ability to launch and grow consumer brands that deeply resonate with their target audiences. Her insights and experience will be instrumental in helping guide our strategic direction and accelerating our growth trajectory,” said Leslie C. G. Campbell, Chairman of the Board. “We are delighted to welcome her to the Board during this transformational period for the Company.”

Sandra Campos, President and CEO, commented, “We are ecstatic to welcome Leah to our Board. Her diverse experience as a consumer-centric, entrepreneurial visionary will be invaluable to our growth. Leah's strategic insight and technology acumen, combined with her passion for pets—including her beloved Maine Coon cat and equestrian pursuits—align perfectly with our commitment to providing exceptional preventive and wellness products for dogs, cats, and horses.”

“I’m excited to join the Board at this pivotal moment in the company’s journey,” said Ms. Solivan. “As the company continues to enhance its technological capabilities and deepen its understanding of consumer needs, we have a tremendous opportunity to expand our position as a trusted go-to leader in our industry. My experience as a pet owner fuels my dedication to our purpose, and I’m eager to collaborate with my fellow Board members to drive growth, expand our market presence, and create lasting value for all stakeholders.”



About Leah Solivan

Ms. Solivan is currently a General Partner at Fuel Capital, a seed stage venture capital firm investing in consumer, software as a service (SaaS) and infrastructure companies. Ms. Solivan has served at Fuel Capital since July 2017.

Before Fuel Capital, Ms. Solivan created one of the most widely recognized new consumer technology brands of the past decades with TaskRabbit, the pioneering on-demand marketplace company she founded in 2008. As TaskRabbit’s CEO for eight years, Leah scaled the company into an international business with operations in 44 cities and more than $50 million in venture capital funding. In 2017, Ms. Solivan oversaw TaskRabbit’s successful sale to IKEA, the multinational home decor corporation.

Ms. Solivan began her career as a software engineer at IBM, where she worked for seven years on products including Lotus Notes and Domino.

With over twenty years of experience, Ms. Solivan is a frequent speaker on topics such as entrepreneurship, the future of work, and women in technology. Ms. Solivan’s achievements have been featured in publications including the Wall Street Journal, Wired, and Time, and Fast Company named her one of the “100 Most Creative People in Business.” Ms. Solivan holds a Bachelor of Science degree in Mathematics and Computer Science from Sweet Briar College, where she has served on the Board of Directors.

About

Founded in 1996, PetMeds is a leader in the digital pet pharmacy industry. As a national online retailer, PetMeds.com and PetCareRx.com are top choices for delivering preventive and chronic symptom prescriptions and OTC medications and products through their thousands of veterinary partners and a loyal customer base. Leveraging telehealth and insurance partnerships, they offer unparalleled value and convenience to pet parents at every stage of their pets' lives, whether dogs, cats, or horses. PetMeds and PetCareRx provide a comprehensive range of medications, food products, and essential supplies through their websites, and .

Forward Looking Statement

This press release may contain “forward-looking statements”, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such forward-looking statements are set forth in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in the Company’s Annual Report on Form 10-K for the year ended March 31, 2024. The Company’s future results may also be impacted by other risk factors listed from time to time in the Company’s filings with the Securities and Exchange Commission, including, but not limited to, the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and periodic filings on Form 8-K. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release and should not be relied upon as representing the Company’s views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements, other than as may be required by law. If the Company does update one or more forward-looking statements, no inference should be made that the Company will make additional updates with respect to those or other forward-looking statements.

Investor Contact:

ICR, LLC

John Mills

(646) 277-1254

Reed Anderson

(646) 277-1260

A photo accompanying this announcement is available at



EN
24/06/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PetMed Express Inc.

 PRESS RELEASE

PetMed Express Receives Notification of Deficiency from Nasdaq Related...

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K DELRAY BEACH, Fla., July 03, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (“PetMeds®”) (NASDAQ: PETS) received on July 2, 2025, an expected notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 (the “Form 10-K”), with the Securities and Exchange Commission (“SEC”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) ...

 PRESS RELEASE

PetMed Express, Inc. Provides Update on Status of Fourth Quarter and F...

PetMed Express, Inc. Provides Update on Status of Fourth Quarter and FY 2025 Results and Form 10-K Filing DELRAY BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (the “Company”) dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today provided an update on the status of its fourth quarter and FY 2025 results and 10-K filing. On June 16, 2025, the Company filed a Form 12b-25 (the “Form 12b-25”) disclosing that the Company would be unable to file its Form 10-K for the year ended March 31, 2025 (the “2025 Form 10-K”) within the prescribed period without unreasonab...

 PRESS RELEASE

PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 ...

PetMed Express, Inc. Announces Preliminary Fourth Quarter and FY 2025 Results and Filing of Form 12b-25 DELRAY BEACH, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced preliminary fourth quarter and fiscal year 2025 results and filed Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission. The Company is unable to file its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 within the prescribed time period without unreasonable effort or expense. The Company ...

 PRESS RELEASE

PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year...

PetMed Express, Inc. Announces Delay in Fourth Quarter and Fiscal Year End Earnings Release and Conference Call DELRAY BEACH, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced it is delaying the release of the Company’s fourth quarter and fiscal year 2025 earnings release and subsequent conference call, which had been scheduled for June 10, 2025, because the Company requires additional time to complete the year-end audit process. The Company anticipates that it will issue the earnings release, hold the ...

 PRESS RELEASE

PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Ear...

PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2025 Earnings Call DELRAY BEACH, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- , dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) will hold a conference call on Tuesday, June 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fourth quarter and full fiscal year ended March 31, 2025. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch